Parabilis Medicines is gearing up for an IPO that could eventually bring in as much as $476m to fund the phase 3 development of its desmoid tumor prospect.
British medtech startup IMU Biosciences has landed a £40m series A as it looks to move immune system analysis from analog to “high definition.”
Flok Health raises £9.5m to scale its AI clinician
Warsaw-based AI biology company Ingenix has raised €13m in a seed-extension financing round led by Sofinnova Partners
Subtle Medical raises $33m, appoints new CEO to advance AI image software
Semble has raised a £30m Series C funding round to accelerate its healthcare management platform for outpatient providers.
CereVasc has raised $85m from investors including Johnson & Johnson’s corporate venture capital arm and Medtronic.
Veritas Aortic Solutions, the latest company to spin out of inQB8 Medical Technologies has announce the closing of $12m in Seed financing
Alnylam has partnered with the person who helped put the “T” in ChatGPT, paying $30 million to work with Jakob Uszkoreit’s Inceptive Nucleics on artificial intelligence-enabled drug design.
Ascidian Therapeutics and Lilly ink RNA exon editing pact worth up to $1.9B for genetic kidney diseases
Gnosis Health secures £1.1m to accelerate Parkinson’s care
Anti-aging startup NewLimit is back with a fresh fundraise of $435 million after landing on its first clinic-ready candidate years earlier than expected.
Sussex Based Joyvié Health has closed its pre-seed funding round, raising a total of $1.04m (£771k) in angel investment and Innovate UK grant funding
===============
Newton Colmore is a specialist search firm and we connect exceptional engineering and scientific talent with impactful companies, globally.